Rating History for 8/14/2026
| Company (Firm - Analyst) | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details | ||
|---|---|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics
(H.C. Wainwright - Matthew Caufield) |
FDMT | Maintain | Buy (Buy) |
36.00 (N/A) |
|
Details | |||
| Abeona Therapeutics
(Oppenheimer - Jeff Jones) |
ABEO | Maintain | Outperform (N/A) |
21.00 (22.00) |
|
Details | |||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 302 more... | |||||||||


